Medical Technologies Guidance MTG54
NICE conclude that the VAC Veraflo Therapy system shows promise for treating acute infected or chronic wounds that are not healing. However there is not enough good-quality evidence to support the case for routine adoption. Although there are potential benefits for patients and the NHS, more evidence is needed to be certain of VAC Veraflo Therapy system’s clinical effectiveness and potential for cost savings compared with negative pressure wound therapy
NICE, UK | United Kingdom
21.02.2021
Added: 21.02.2021
Classifications: Breast & Oncoplastic Surgery
Keywords: Negative Pressure Wound Dressings